BAILARD, INC.

Position in NVS — Novartis AG

CIK 750641 Foster City, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$2,173,549

+$144,724 QoQ

Shares Held

13,869

+4.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#410

of 1,603 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BAILARD, INC. holds $201,504,836 across 13 Drug Manufacturers - General names. NVS ranks #8 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	734,610	$92,810,627
2	JNJ	Johnson & Johnson	147,802	$37,537,273
3	AMGN	Amgen Inc	49,586	$17,956,082
4	LLY	ELI LILLY & Co	13,510	$16,204,300
5	ABBV	AbbVie Inc.	55,207	$13,892,289
6	AZN	Astrazeneca PLC	70,691	$13,404,427
7	MRK	Merck & Co., Inc.	26,669	$3,426,966
8	NVS	Novartis AG This page	13,869	$2,173,549

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,173,549	13,869	+4.4%	Shares	Sole	2026-07-30
2026-03-31	$2,028,825	13,282	-7.9%	Shares	Sole	2026-05-11
2025-12-31	$1,988,912	14,426	+19.0%	Shares	Sole	2026-02-04
2025-09-30	$1,554,397	12,121	+13.2%	Shares	Sole	2025-10-30
2025-06-30	$1,295,170	10,703	+5.7%	Shares	Sole	2025-08-08
2025-03-31	$1,128,512	10,123	+69.8%	Shares	Sole	2025-05-02
2024-12-31	$580,259	5,963	+5.0%	Shares	Sole	2025-02-05
2024-09-30	$653,313	5,680	+39.0%	Shares	Sole	2024-10-30
2024-06-30	$435,102	4,087	+19.3%	Shares	Sole	2024-07-25
2024-03-31	$331,396	3,426	-62.3%	Shares	Sole	2024-05-08
2020-12-31	$858,179	9,088	+6.4%	Shares	Sole	2021-02-03
2020-09-30	$742,464	8,538	+6.0%	Shares	Sole	2020-11-10
2020-06-30	$703,349	8,053	+62.7%	Shares	Sole	2020-08-12
2020-03-31	$408,209	4,951	—	Shares	Sole	2020-04-16
No filing history on record for this holder in this stock.